Fingerprint
Dive into the research topics of 'Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically